Brainsway (BWAY) Research & Development (2018 - 2026)
Brainsway (BWAY) posted quarterly Research & Development of $4.9 million for Q1 2026, up 18.45% year-on-year from $4.2 million in Q1 2025, and down 3.37% on a QoQ basis from $5.1 million in Q4 2025.
Brainsway (BWAY) Research & Development (2018 - 2026) Analysis & Trends
Brainsway (BWAY) has reported Research & Development for 9 consecutive years, with $4.9 million the latest figure, recorded in Q1 2026.
- Quarterly Research & Development rose 18.45% year-over-year to $4.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.3 million (down 7.64% YoY) and the FY2025 annual result came in at $9.6 million, up 33.56% from the prior year.
- Research & Development fell to $4.9 million in Q1 2026 per BWAY's latest filing, from $5.1 million in the prior quarter.
- Over the last five years, Research & Development for BWAY reached as high as $5.1 million in Q4 2025 and fell as low as $514000.0 in Q2 2025.
- A 5-year average of $4.1 million and a median of $4.2 million in 2025 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2022 — Research & Development jumped 32.5% — and 2025, when it slumped 86.46%.
- Year by year, Research & Development stood at $4.8 million in 2022, then declined by 16.65% to $4.0 million in 2023, then rose by 12.96% to $4.5 million in 2024, then grew by 14.09% to $5.1 million in 2025, then fell by 3.37% to $4.9 million in 2026.
- According to Business Quant data, Research & Development over the past three periods registered $4.9 million, $5.1 million, and $4.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 145.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -461.27 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Brainsway | 646.63 Mn | 587.74 Mn | 11.68 Mn | 4.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.93 Mn |
| Dec 31, 2025 | 5.10 Mn |
| Sep 30, 2025 | 4.73 Mn |
| Jun 30, 2025 | 514,000.00 |
| Mar 31, 2025 | 4.16 Mn |
| Dec 31, 2024 | 4.47 Mn |
| Sep 30, 2024 | 4.11 Mn |
| Jun 30, 2024 | 3.80 Mn |
| Mar 31, 2024 | 3.83 Mn |
| Dec 31, 2023 | 3.96 Mn |
| Sep 30, 2023 | 3.60 Mn |
| Jun 30, 2023 | 3.98 Mn |
| Mar 31, 2023 | 4.91 Mn |
| Dec 31, 2022 | 4.75 Mn |
| Sep 30, 2022 | 4.75 Mn |
| Jun 30, 2022 | 4.55 Mn |
| Mar 31, 2022 | 4.15 Mn |
| Dec 31, 2021 | 4.52 Mn |
| Sep 30, 2021 | 4.04 Mn |
| Jun 30, 2021 | 4.19 Mn |